NCT03975829 2026-04-02Pediatric Long-Term Follow-up and Rollover StudyNovartisPhase 4 Active not recruiting163 enrolled
NCT02386800 2026-03-16CINC424A2X01B Rollover ProtocolNovartisPhase 4 Active not recruiting279 enrolled
NCT06748001 2026-02-09Avapritinib Rollover StudyBlueprint Medicines CorporationPhase 4 Recruiting60 enrolled